The FDA expanded its approval of remdesivir, known by the brand name Veklury, April 25 to include infants and children 28 days and older weighing at least 7 pounds.
Read the full post on Becker's Hospital Review - Healthcare News
FDA approves 1st COVID-19 treatment for young children
